CLINICAL_TRIALS
trial_result
· 2018-06-11
Clinical Trial Update: A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia [Phase 3]
Summary
Phase 3 trial of ferumoxytol for episodic treatment of iron deficiency anemia completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AMAG Pharmaceuticals, Inc. | Conditions: Iron Deficiency Anemia | Phase 3 | Status: COMPLETED | Results posted: 2018-06-11